Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.030 | 1.000 | 3 | 1997 | 2019 | ||||||
Malignant neoplasm of breast
|
3417 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.020 | 1.000 | 2 | 2010 | 2019 | ||||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
Carcinoma of lung
|
1204 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Childhood Non-Hodgkin Lymphoma
|
39 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1 | 2007 | 2007 | |||||||
Endometrial Carcinoma
|
326 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
Leukemia, Myelocytic, Acute
|
6892 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Lymphoma, Non-Hodgkin
|
197 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
Lymphoma, Non-Hodgkin, Familial
|
79 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
Malignant neoplasm of endometrium
|
197 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
Malignant neoplasm of kidney
|
22 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Malignant neoplasm of lung
|
1142 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Malignant Neoplasms
|
1641 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Nasopharyngeal carcinoma
|
320 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 1995 | 1995 | ||||||
Neoplasms
|
1644 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 1995 | 1995 | ||||||
Primary malignant neoplasm
|
1374 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Renal carcinoma
|
21 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Renal Cell Carcinoma
|
288 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1 | 2007 | 2007 | |||||||
Skin toxicity
|
24 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Squamous cell carcinoma
|
257 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Squamous cell carcinoma of lung
|
283 | 0.677 | 0.360 | 17 | 7674886 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2007 | 2007 |